ArticleOncogene2024
Lysine methyltransferase SMYD2 enhances androgen receptor signaling to modulate CRPC cell resistance to enzalutamide.
Junhong Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ArticleOncogene2024
Junhong Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.